Italia markets closed

BMY Dec 2024 46.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
3,1000+0,5100 (+19,69%)
In data: 03:20PM EDT. Mercato aperto.
Schermo intero
Chiusura precedente2,5900
Aperto3,0900
Denaro3,1000
Lettera3,2500
Prezzo d'esercizio46,00
Scadenza2024-12-20
Min-Max giorno3,0900 - 3,1000
Contratto - Min-MaxN/D
Volume2
Open Interest234
  • GlobeNewswire

    Arbutus Appoints Two New Executives

    Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri